Congenital Muscular Dystrophy Type 1A
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Congenital Muscular Dystrophy Type 1A

What is the definition of Congenital Muscular Dystrophy Type 1A?
Congenital muscular dystrophy type 1A (MDC1A) belongs to a group of neuromuscular disorders that beings at birth or infancy and is characterized mainly by hypotonia, muscle weakness and muscle wasting. Other signs and symptoms include rigidity of the spine; scoliosis; and delayed, limited motor development, with most individuals needing assistive devices for mobility. Respiratory problems, feeding disorders and seizures may also occur. With time, affected individuals may develop an elongated face and ophthalmoplegia disorders (paralysis or weakness in muscles of the eye). Intellectual development is typically normal. It is caused by genetic changes in the LAMA2 gene and is inherited in an autosomal recessive manner.
What are the alternative names for Congenital Muscular Dystrophy Type 1A?
  • Congenital muscular dystrophy type 1A
  • Muscular dystrophy white matter spongiosis
  • LAMA2-related muscular dystrophy
  • Laminin alpha-2 deficiency
  • MDC1A
  • Merosin-deficient congenital muscular dystrophy
  • Merosin-negative congenital muscular dystrophy
  • Muscular dystrophy, congenital, merosin-deficient
  • Atrophie blanche
Who are the top Congenital Muscular Dystrophy Type 1A Local Doctors?
Advanced in Congenital Muscular Dystrophy Type 1A
Advanced in Congenital Muscular Dystrophy Type 1A
Referral required

Amc

47 New Scotland Ave, 
Albany, NY 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Matthew Murnane is a Neurologist practicing medicine in Albany, New York. Dr. Murnane is rated as an Advanced provider by MediFind in the treatment of Congenital Muscular Dystrophy Type 1A. He is also highly rated in 66 other conditions, according to our data. His clinical expertise encompasses Hereditary Sensory Neuropathy Type 1 (HSN1), Andermann Syndrome, Sensorimotor Polyneuropathy, and Septic Arthritis. Dr. Murnane is currently accepting new patients.

Experienced in Congenital Muscular Dystrophy Type 1A
Neuroradiology | Neurology
Experienced in Congenital Muscular Dystrophy Type 1A
Neuroradiology | Neurology
Referral may be required

OSF Illinois Neurological Institute - Neurology

200 East Pennsylvania Avenue, 
Peoria, IL 
Languages Spoken:
English
Accepting New Patients

Christopher Zallek is a Neuroradiologist and a Neurologist practicing medicine in Peoria, Illinois. Dr. Zallek is rated as an Experienced provider by MediFind in the treatment of Congenital Muscular Dystrophy Type 1A. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Myasthenia Gravis, Peripheral Neuropathy, Spinal and Bulbar Muscular Atrophy, and Spinal Muscular Atrophy Type 3. Dr. Zallek is board certified in American Board Of Electrodiagnostic Medicine and American Board Of Psychiatry And Neurology. Dr. Zallek is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Congenital Muscular Dystrophy Type 1A
Family Medicine
Experienced in Congenital Muscular Dystrophy Type 1A
Family Medicine

MUSC Health Primary Care

3351 Maybank Highway, 
Johns Island, SC 
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Adrian Strand is a primary care provider, practicing in Family Medicine in Johns Island, South Carolina. Dr. Strand is rated as an Experienced provider by MediFind in the treatment of Congenital Muscular Dystrophy Type 1A. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Trigeminal Neuralgia, Sickle Cell Disease, Myelitis, and HIV/AIDS. Dr. Strand is currently accepting new patients.

What are the latest Congenital Muscular Dystrophy Type 1A Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center